Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 16/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4777198 | 0.90 | ESR1 (0.53) | ESR1PTGS1PTGS2ESR2AR | |
| SCHEMBL4776835 | 0.86 | ESR1 (0.48) | ESR1PTGS1PTGS2ESR2AR | |
| SCHEMBL4776198 | 0.82 | ESR1 (0.55) | ESR1PTGS1PTGS2ESR2AR | |
| SCHEMBL4778476 | 0.80 | TP53 (0.43) | PTGS1PTGS2LMNA | |
| SCHEMBL4778456 | 0.74 | ESR1 (0.56) | ESR1ESR2ARLMNASMN1; SMN2 | |
| SCHEMBL4779727 | 0.70 | TP53 (0.41) | LMNASMN1; SMN2 | |
| SCHEMBL27744547 | 0.67 | ESR1 (0.56) | ESR1PTGS1PTGS2ESR2 | |
| SCHEMBL3684267 | 0.67 | ESR1 (0.70) | ESR1PTGS1PTGS2ESR2 | |
| SCHEMBL2477255 | 0.67 | ESR1 (0.74) | ESR1ESR2 | |
| SCHEMBL27744548 | 0.63 | CSNK2A2 (0.62) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1889617-A1 | Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents | Freie Universität Berlin (DE) | 2008-02-20 | — | — | EP | claimed |
| EP-1889617-A1 | Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents | Freie Universität Berlin (DE) | 2008-02-20 | — | — | EP | disclosed |